Table 1.

Descriptive Baseline Characteristics from the DanRisk study population.

Age (mean (SD))		55.3	(5.0)
Age 50 (n (%))		600	(49.5 %)
Age 60 (n (%))		611	(50.45 %)
Sex (n (%))
men		569	(47.0 %)
women		642	(53.0 %)
Body mass index (mean (SD))		27.0	(4.8)
Smoking Status (n (%))
Never		500	(41.3 %)
Former smoker		405	(33.4 %)
Current smoker		306	(25.3 %)
Family History of CVD (n (%))		282	(23.3 %)
Hypertension (n (%))		253	(20.9 %)
Diabetics (n (%))		35	(2.9 %)
Hyperlipidemia (n (%))		937	(77.4 %)
Statin users (n (%))		142	(11.7 %)
Biomarkers
Triglycerides, mmol/L (n, mean (SD))	1211	1.56	(1.07)
HDL, mmol/L (n, mean (SD))	1211	1.52	(0.47)
LDL, mmol/L (n, mean (SD))	1211	3.25	(0.91)
Total Cholesterol, mmol/L (n, mean (SD))	1211	5.49	(1.03)
Calcium, mmol/L (n, mean (SD))	1111	2.34	(0.09)
Phosphate, mmol/L (n, mean (SD))	1116	1.10	(0.18)
CPP, mmol2/L2 (n, mean (SD))	1111	2.57	(0.43)
Vitamin D2 & D3, nmol/L (n, mean (SD))	1147	59.35	(24.00)
PTH, pmol/L (n, mean (SD))	1152	3.66	(1.97)
OPG, nmol/L (n, mean (SD))	1175	1.88	(0.59)
Troponine, ng/L (mean (SD))	1175	6.34	(24.78)
CRP, mg/L (n, mean (SD))	1179	2.89	(4.92)
SuPAR, ng/L (n, mean (SD))	1175	2.83	(0.97)
Creatinine, μmol/L (n, mean (SD))	1142	71.38	(16.87)
Cystatin C, mg/L (n, mean (SD))	1116	0.93	(0.17)
Urate, mmol/L (n, mean (SD))	1116	1.31	(32.71)
EGFR, mL/min (n, mean (SD))	1113	92.61	(12.11)
ABI (n, mean (SD))	1205	1.12	(0.13)
CAC score
CAC = 0 (n (%))		666	(55.1 %)
CAC 1–99 (n (%))		364	(30.1 %)
CAC 100–399 (n (%))		112	(9.3 %)
CAC ≥400 (n (%))		66	(5.5 %)